Clinical Study of SU 11248 (Sutent) Combined With Standard Chemotherapy in Patients With FLT3 Mutated AML Over 60 Years

NCT00783653 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
22
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Universitätsklinikum Hamburg-Eppendorf